63% pCR Rate with Neoadjuvant Nivolumab + Relatlimab in Resectable Melanoma Melanoma Skin Cancer Treatment 4 Mins Read Introduction to Neoadjuvant Therapy for Melanoma Neoadjuvant therapy is changing how we treat melanoma, offering big benefits over traditional adjuvant…
